Study Reveals Low Rates of Gender-Affirming Medication Among Adolescents - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Health

Study Reveals Low Rates of Gender-Affirming Medication Among Adolescents

share-iconTuesday, January 07 comment-icon3 weeks ago 8 views
News sources:
thehillTHEHILL
Study Reveals Low Rates of Gender-Affirming Medication Among Adolescents

Credited from: THEHILL

  • Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication from 2018 to 2022, according to a new study.
  • Researchers analyzed data from over 5 million patients aged 8 to 17, finding 926 received puberty blockers and 1,927 received hormones.
  • As legal discussions continue, 26 states have enacted laws restricting gender-affirming care for minors, and the Supreme Court is reviewing related cases.
  • The study highlights that gender-affirming care is associated with improved psychological functioning for transgender youth, despite ongoing controversy.
  • Lead researcher Landon Hughes expressed hope that these findings would help alleviate concerns about the prevalence of such care among adolescents.

For more information, visit the original article here.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture